Johnson & Johnson's new drugs may offset declining sales due to patent-protection losses.

The odds that SpaceX can achieve its space goals by 2028 are fairly slim. It's more likely that its AI and connectivity ...

SPMO is up 30% year-to-date, compared to 13% for Vanguard's ETF. It has a one-year return of 32% versus 20% for VOO, and a ...

Joby ended the second quarter of 2026 with about $2.3 billion in cash and short-term securities. It has more cash than debt, ...

Tiger Global's Chase Coleman was busy buying Cerebras and Intel stock in Q2.

The total return for the S&P 500 ( ^GSPC +0.21%) during the first half of 2026 was 10.2%. That puts the index in some unique ...

Please refer to the forward-looking statements contained in the earnings release published today, as well as the most recent ...

Palantir's growth continues to accelerate. Palantir doesn't need to convince investors that it will benefit from some future ...

A lot of people pledge to save well for retirement only to have life get in the way. Stagnant wages, surprise expenses, and ...

Anthropic's revenue is exploding -- and Amazon and SpaceX are cashing in on the AI boom before any IPO even happens.

The ability to pull your original contributions out penalty-free is an underrated perk that makes this retirement account ...

Gen X carries the highest card balances of any generation. See where you land, what carrying a balance costs, and how to ...